You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

High-Risk Localized Prostate Cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer, Radical Prostatectomy Trial in Houston (REGN5678, Piflufolastat F18)

Not yet recruiting
  • Prostate Cancer
  • Radical Prostatectomy
  • Houston, Texas
    MD Anderson Cancer Center
Oct 10, 2023

Prostate Cancer Trial in Baltimore (Enoblituzumab, Standard of Care)

Not yet recruiting
  • Prostate Cancer
  • Baltimore, Maryland
    Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Aug 25, 2023

High-Risk Prostate Cancer Trial in Portland (Capivasertib, abiraterone acetate)

Not yet recruiting
  • High-Risk Prostate Cancer
  • Portland, Oregon
    VA Portland Health Care System, Portland, OR
Jan 17, 2023

Prostate Cancer, Prostate Adenocarcinoma Trial (drug, other, procedure)

Not yet recruiting
  • Prostate Cancer
  • Prostate Adenocarcinoma
  • (no location specified)
Feb 2, 2023

Localized Prostate Cancer Participants Treated With Radical

Not yet recruiting
  • High Risk Localized Prostate Cancer
    • Akita, Japan
      Akita University Hospital
    Aug 2, 2022

    Prostate Cancer Trial in Beijing (Darolutamide+ADT)

    Not yet recruiting
    • Prostate Cancer
    • Beijing, China
      Peking University First Hospital
    Sep 1, 2023

    Prostate Cancer Trial in Vancouver, Toronto (Apalutamide 60mg Tab, Abiraterone Acetate 250mg, Prednisone 5mg Tab)

    Recruiting
    • Prostate Cancer
    • Apalutamide 60mg Tab
    • +5 more
    • Vancouver, British Columbia, Canada
    • +1 more
    May 25, 2022

    Prostate Cancer, Cancer of Prostate Trial in Saint Louis (Dapagliflozin, BIOSENSE Meter)

    Not yet recruiting
    • Prostate Cancer
    • Cancer of Prostate
    • Saint Louis, Missouri
      Washington University School of Medicine
    Nov 19, 2021

    Prostate Cancer Trial in Portland (Intensity-Modulated Radiation Therapy (IMRT), Docetaxel+IMRT)

    Active, not recruiting
    Has Results
    • Prostate Cancer
    • Portland, Oregon
    • +1 more
    Apr 19, 2022

    Prostate Cancer Trial in Nanning (Darolutamide 300 mg, Androgen deprivation therapy)

    Not yet recruiting
    • Prostate Cancer
    • Darolutamide 300 mg
    • Androgen deprivation therapy
    • Nanning, Jiangsu, China
      Hongqian Guo
    Feb 19, 2022

    ATM Gene Mutation, BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Sacramento (Niraparib, Niraparib Tosylate Monohydrate,

    Recruiting
    • ATM Gene Mutation
    • +16 more
    • Sacramento, California
      University of California Davis Comprehensive Cancer Center
    Oct 27, 2022

    Neoadjuvant Therapy Trial in Nanjing (pamiparib, abiraterone, prednisone)

    Recruiting
    • Neoadjuvant Therapy
    • Nanjing, Jiangsu, China
    • +2 more
    Jan 3, 2023

    Prostate Adenocarcinoma Trial in Salt Lake City (MVA-BN-Brachyury)

    Withdrawn
    • Prostate Adenocarcinoma
    • MVA-BN-Brachyury
    • Salt Lake City, Utah
      Huntsman Cancer Institute
    Sep 21, 2021

    Prostate Cancer, Low-risk or Favorable Intermediate Risk Prostate Cancer Who Are on an Active Surveillance Regimen Trial in San

    Recruiting
    • Prostate Cancer
    • Low-risk or Favorable Intermediate Risk Prostate Cancer Who Are on an Active Surveillance Regimen
    • TRANBERG®|Thermal Therapy System
    • San Diego, California
      Genesis Research LLC.
    Apr 12, 2023

    Prostate Cancer Trial in New York (BMS-986218 and Degarelix, Degarelix)

    Recruiting
    • Prostate Cancer
    • New York, New York
      Columbia University Irving Medical Center
    Oct 27, 2021

    Cancer Of Prostate Trial run by the National Cancer Institute (NCI) (M9241, Stereotactic Body Radiation Therapy (SBRT))

    Recruiting
    • Cancer Of Prostate
    • M9241
    • Stereotactic Body Radiation Therapy (SBRT)
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Prostate Cancer Trial (Hypofractionated IMRT Radiation treatment)

    Active, not recruiting
    • Prostate Cancer
    • Hypofractionated IMRT Radiation treatment
    • (no location specified)
    Sep 27, 2022

    Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8, Stage IIIA Prostate Cancer AJCC v8 Trial in Houston (biological,

    Active, not recruiting
    • Prostate Adenocarcinoma
    • +5 more
    • Daratumumab
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 25, 2022

    Prostate Cancer Trial in Baltimore (Enoblituzumab)

    Active, not recruiting
    Has Results
    • Prostate Cancer
    • Baltimore, Maryland
      Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
    Aug 16, 2022

    Prostate Adenocarcinoma Trial in Park Ridge (CyberKnife, Androgen Deprivation Therapy (ADT), Intensity Modulated radiation

    Recruiting
    • Prostate Adenocarcinoma
    • CyberKnife
    • +2 more
    • Park Ridge, Illinois
      Advocate Lutheran General Hospital
    Jul 19, 2021

    Prostate Cancer Patients Trial in Qingdao, Shanghai (Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin)

    Recruiting
    • Prostate Cancer Patients
    • Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin
    • Qingdao, Shandong, China
    • +1 more
    May 3, 2022

    Adenocarcinoma of the Prostate, Stage III Prostate Cancer Trial in Los Angeles (radiation, other, drug)

    Active, not recruiting
    • Adenocarcinoma of the Prostate
    • Stage III Prostate Cancer
    • stereotactic body radiation therapy
    • +3 more
    • Los Angeles, California
      Jonsson Comprehensive Cancer Center
    Apr 28, 2022

    Castrate Resistant Prostate Cancer Trial in Chicago, Indianapolis, Hershey (Ipatasertib, Darolutamide, Androgen Deprivation

    Recruiting
    • Castrate Resistant Prostate Cancer
    • Chicago, Illinois
    • +2 more
    Jul 19, 2022

    Prostate Cancer Trial in Toronto (Conventionally Fractionated versus Hypofractionated Boost)

    Active, not recruiting
    • Prostate Cancer
    • Conventionally Fractionated versus Hypofractionated Boost
    • Toronto, Ontario, Canada
      Sunnybrook Odette Cancer Centre
    Mar 6, 2022

    Prostate Cancer Trial in Lexington (biological, drug, radiation)

    Not yet recruiting
    • Prostate Cancer
    • Pembrolizumab
    • +3 more
    • Lexington, Kentucky
      University of Kentucky
    Oct 3, 2022